Uppsala Therapeutics AB
559027-4204ActiveDeveloping nanoparticle platforms for targeted drug delivery across the BBB.
Oversikt
- 0
- Ansatte
- ≤1t SEK
- Omsetning
- 2015
- Grunnlagt
Nøkkelbeslutningstakere
Oommen Varghese
Co-Founder, Chief Scientific Officer (CSO)
Jöns Hilborn
Co-Founder
Victor Hartman
CEO
O. P. Oommen
Co-Founder
Beskrivelse
Uppsala Therapeutics is an innovative biopharmaceutical company specializing in advanced drug delivery systems. The core of their work involves developing proprietary nanoparticle-based therapies designed to carry small molecule and oligonucleotide drugs. Their technology originates from cutting-edg...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559027420401
Beslutningstakere
4 kontakter i FunnelfeedrOommen Varghese
Co-Founder, Chief Scientific Officer (CSO)
Jöns Hilborn
Co-Founder
Victor Hartman
CEO
O. P. Oommen
Co-Founder
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrKey2Brain AB
10–19 ansatteDeveloping proprietary technology for next-generation brain targeting therapeutics.
Double Bond Pharmaceutical AB
5–9 ansatteDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
Ambusol AB (publ)
1–4 ansattePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Strike Pharma AB
4 ansatteSwedish biotech developing targeted LNP delivery for in vivo CAR-T therapies.
Theralia AB
0 ansattePioneering biotech revolutionizing drug delivery via TOUCAN technology.
Utforsk mer
Spørsmål om Uppsala Therapeutics AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo